Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis

Background: Venous thromboembolism (VTE) is highly prevalent in cancer patients. Recent guidelines recommend considering direct oral anticoagulants (DOACs) for the treatment of cancer-associated thrombosis (CAT). However, direct head-to-head comparisons among DOACs are lacking, and almost no net cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yi-Dan, Ding, Zheng, Pan, Mang-Mang, Xia, Qing, Cui, Jiu-Jie, Wang, Li-Wei, Zhang, Chi, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693545/
https://www.ncbi.nlm.nih.gov/pubmed/33304929
http://dx.doi.org/10.3389/fcvm.2020.586020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693545/
https://www.ncbi.nlm.nih.gov/pubmed/33304929
http://dx.doi.org/10.3389/fcvm.2020.586020

Ejemplares similares